Skip to main content

Advertisement

Fig. 10 | Cancer Cell International

Fig. 10

From: Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients

Fig. 10

The decision curve analysis of prognostic signature: decision curve analysis for 1-year disease free survival (a); decision curve analysis for 3-year disease free survival (b); decision curve analysis for 5-year disease free survival (c). The y-axis represented the net benefit. The red solid line represented the prognostic signature. The grey solid line represented the net benefit of treating all patients within 1-, 3-, and 5-year. The black solid line represented the net benefit of treating no patients within 1-, 3-, and 5-year

Back to article page